In a very modern examine, we documented the identification as well as characterization of a whole new atypical opioid receptor with special detrimental regulatory properties toward opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a broad-spectrum